The genetics of dominant osteopetroses

Drug Discovery Today: Disease Mechanisms

Volumn 2, Issue 4, 2005, Pages 503-509

  Frattini, Annalisa ^a   Vezzoni, Paolo ^a   Villa, Anna ^a  

^a CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CALCIUM ION; CHLORIDE CHANNEL; FRIZZLED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; WNT PROTEIN;

ALBERS SCHOENBERG DISEASE; AUTOSOMAL DOMINANT DISORDER; BONE RADIOGRAPHY; CELL FUNCTION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; MISSENSE MUTATION; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOSCLEROSIS; PATHOGENESIS; PELVIC GIRDLE; PHENOTYPE; REVIEW; SKULL; SKULL BASE; SPINE; SPINE RADIOGRAPHY;

EID: 33645066097     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2005.10.002     Document Type: Review

References (48)

1. P. Ash et. al. Osteoclasts derived from haematopoietic stem cells Nature 283 1980 669-670
2. G. Karsenty E.F. Wagner Reaching a genetic and molecular understanding of skeletal development Dev. Cell 2 2002 389-406
3. R.T. Moon et. al. The promise and perils of Wnt signalling through beta-catenin Science 296 2002 1644-1646
4. D.A. Glass II et. al. Canonical Wnt signalling in differentiated osteoblasts controls osteoclast differentiation Dev. Cell 8 2005 751-764
5. J.J. Westendorf et. al. Wnt signaling in osteoblasts and bone diseases Gene 341 2004 19-39
6. C.Y. Logan R. Nusse The Wnt signalling pathway in development and disease Annu. Rev. Cell Dev. Biol. 20 2004 781-810
7. Y. Gong et. al. LDL receptor related protein 5(LRP5) affects bone accrual and eye development Cell 107 2001 513-523
8. M. Kato et. al. Cbfa1-independent decrease in osteoblast proliferation, ostepenia and persistent embryonic eye vascularization in mice deficient in Lrp5 a Wnt coreceptor J. Cell Biol. 157 2002 303-314
9. R.D. Little et. al. A mutation in the LDL receptor related protein 5 gene results in the autosomal dominant high bone mass trait Am. J. Hum. Genet. 70 2002 11-19
10. M.A. Koay M.A. Brown Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton Trends Mol. Med. 11 2005 129-137
11. W.J. Boley et. al. Osteoclast differentiation and activation Nature 423 2003 337-342
12. H.C. Blair N.A. Athanasou Recent advances in osteoclast biology and pathological bone resorption Histol. Histopathol. 19 2004 189-199
13. S.L. Teitelbaum F.P. Ross Genetic regulation of osteoclast development and function Nat. Rev. Genet. 4 2003 638-649
14. W.S. Sly et. al. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification Proc. Natl. Acad. Sci. U S A 80 1983 2752-2756
15. K.H. Vaananen et. al. The cell biology of osteoclast function J. Cell Sci. 113 2000 377-381
16. J.P. Ly et. al. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification Nat. Genet. 23 1999 447-451
17. J.C. Scimeca et. al. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants Bone 26 2000 207-213
18. A. Frattini et. al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis Nat. Genet. 25 2000 343-346
19. U. Kornak et. al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man Cell 104 2001 205-215
20. N. Chalhoub et. al. Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human Nat. Med. 9 2003 399-406
21. P.E. Andersen J. Bollerslev Heterogeneity of autosomal dominant osteopetrosis Radiology 164 1987 223-225
22. J. Bollerslev Autosomal dominant osteopetrosis: Bone metabolism and epidemiological, clinical and hormonal aspects Endocr. Rev. 10 1989 45-67
23. E. Van Hul et. al. Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13 J. Bone Miner. Res. 17 2002 1111-1117
24. P.J. Hey et. al. Cloning of a novel member of the low density lipoprotein receptor family Gene 216 1998 103-111
25. M.L. Johnson et. al. Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13) Am. J. Hum. Genet. 60 1997 1326-1332
26. L.M. Boyden et. al. High bone density due to a mutation in LDL-receptor-related protein 5 N. Engl. J. Med. 346 2002 1513-1521
27. M. Ai et. al. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling Mol. Cell. Biol. 25 2005 4946-4955
28. L. Van Wesenbeeck et. al. Six novel missense mutations in the LDL receptor related protein 5 (LRP5) gene in different conditions with an increased bone density Am. J. Hum. Genet. 72 2003 763-771
29. M.L. Kwee et. al. An autosomal dominant high bone mass phenotype in association with craniosynostosis in an extended family is caused by an LRP5 missense mutation J. Bone Miner. Res. 20 2005 1254-1260
30. O. Benichou et. al. Mapping of autosomal dominant osteopetrosis type II (Albers-Schonberg disease) to chromosome 16p13.3 Am. J. Hum. Genet. 69 2001 647-654
31. T. El-Tawil D.J. Stoker Benign osteopetrosis: A review of 42 cases showing two different patterns Skeletal Radiol. 22 1993 587-593
32. O.D. Benichou et. al. Type II autosomal dominant osteopetrosis (Albers-Schonberg disease): Clinical and radiological manifestations in 42 patients Bone 26 2000 87-93
33. S. Waguespack et. al. Chloride channel (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II J. Bone Miner. Res. 18 2003 1513-1518
34. W. Van Hul et. al. Localization of a gene for autosomal dominant osteopetrosis (Albers-Schonberg disease) to chromosome 1p21 Am. J. Hum. Genet. 61 1997 363-369
35. E. Cleiren et. al. Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene Hum. Mol. Gen. 10 2001 2861-2867
36. A. Frattini et. al. Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis J. Bone Miner. Res. 18 2003 1740-1747
37. A.B. Campos-Xavier et. al. Chloride channel 7 (ClCN7) gene mutations in intermediate autosomal recessive osteopetrosis Hum. Genet. 112 2003 186-189
38. S. Waguespack et. al. Measurement of tartrate resistant acid phosphatase and the brain isoenzyme of creatine kinase accurately diagnoses type II autosomal dominant osteopetrosis but does not identify gene carriers J. Clin. Endocrinol. Metab. 87 2002 2212-2217
39. C. Letizia et. al. Type II benign osteopetrosis (Albers-Schonberg disease) caused by a novel mutation in ClCN7 presenting with unusual clinical manifestations Calcif. Tissue Int. 74 2004 42-46
40. K. Henriksen et. al. Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II Am. J. Pathol. 164 2004 1537-1545
41. A.B. Campos-Xavier et. al. Intrafamilial phenotypic variability of osteopetrosis due to chloride channel 7 (CLCN7) mutations Am. J. Med. Genet. 133 2005 216-218
42. C. Toomes et. al. Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q Am. J. Hum. Genet. 74 2004 721-730
43. X. Jiao et. al. Autosomal recessive familial exudative vitreoretinopathy is associated with mutations in LRP5 Am. J. Hum. Genet. 75 2004 878-884
44. J. Carolino et. al. Osteopetrosis Am. Fam. Physician 57 1998 1293-1296
45. L.L. Key Jr. et. al. Long-term treatment of osteopetrosis with recombinant human interferon gamma N. Engl. J. Med. 15 1995 1594-1599
46. M.S. Kocher J.R. Kasser Osteopetrosis Am. J. Orthop. 32 2003 222-228
47. G.J. Driessen et. al. Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: An EBMT report Bone Marrow Transplant. 32 2003 657-663
48. V. Vanier et. al. Bilateral visual improvement after unilateral optic canal decompression and cranial vault expansion in a patient with osteopetrosis, narrowed optic canals, and increased intracranial pressure J. Neurol. Neurosurg. Psychiatry 69 2000 405-406